Insmed | INSM

Aktienkurs
145.15
Täglich Wechseln
2.36 1.65%
Monatlich
0.85%
Jährlich
99.79%
Q2 Prognose
150.58

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-04-30 FY2026Q1 AM -0.99 -1.42
2026-02-19 FY2025Q4 AM -1.54 -1.28 -1.32
2025-10-30 FY2025Q3 AM -1.75 -1.34 -1.27
2025-08-07 FY2025Q2 AM -1.70 -1.36 -1.94
2025-05-08 FY2025Q1 AM -1.42 -1.20 -1.06



Preis Chg Tag Jahr Datum
BioMarin Pharmaceutical 54.40 0.30 0.55% -7.25% 2026-04-17
Cytokinetics 65.46 0.04 0.06% 72.58% 2026-04-17
DBV Technologies 20.61 -0.64 -3.01% 158.27% 2026-04-16
Gilead Sciences 137.64 -0.91 -0.66% 31.09% 2026-04-17
Heron Therapeutics 1.02 0.08 8.51% -44.57% 2026-04-17
Insmed 145.15 2.36 1.65% 99.79% 2026-04-17
Novartis 151.79 1.99 1.33% 37.24% 2026-04-17
Ultragenyx Pharmaceutical 24.52 -0.66 -2.62% -31.30% 2026-04-16
Regeneron Pharmaceuticals 748.28 2.28 0.31% 32.87% 2026-04-17
Sarepta Therapeutics 21.17 -0.56 -2.58% -60.64% 2026-04-16

Preis Tag Jahr Datum
USND 24487 384.58 1.60% 54.29% 2026-04-17
US2000 2778 59.13 2.18% 50.93% 2026-04-17